Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility

by An M. T. Van Nuffel, Caroline Boudousquié, Sandra Tuyaerts, Sandra Tuyaerts
Published 2019-08-01

Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy

by Sandra Tuyaerts, Frédéric Amant
Published 2018-08-01

Potential Therapeutic Targets in Uterine Sarcomas

by Tine Cuppens, Sandra Tuyaerts, Frédéric Amant
Published 2015-01-01

Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity

by Regina E. M. Baiden-Amissah, Sandra Tuyaerts
Published 2019-07-01

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer

by Sandra Tuyaerts, Sandra Tuyaerts, Klara Rombauts, Tina Everaert, An M. T. Van Nuffel, Frédéric Amant, Frédéric Amant, Frédéric Amant
Published 2019-01-01

Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?

by Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts, Diether Lambrechts, Frédéric Amant
Published 2021-04-01

Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?

by Regina Esi Mensimah Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts, Frederic Amant
Published 2021-08-01

Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

by Rita Ahmed, Isaac Crespo, Sandra Tuyaerts, Amel Bekkar, Michele Graciotti, Ioannis Xenarios, Lana E. Kandalaft
Published 2020-01-01

In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer

by Anke Vanderstraeten, Sandra Tuyaerts, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Cathérine Luyten, Frederic Amant
Published 2016-09-01

Intratumoral Combinatorial Administration of CD1c (BDCA-1)⁺ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Pa...

by Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Published 2020-11-01

The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer

by Oliviero Marinelli, Maria Beatrice Morelli, Daniela Annibali, Cristina Aguzzi, Laura Zeppa, Sandra Tuyaerts, Consuelo Amantini, Frédéric Amant, Benedetta Ferretti, Federica Maggi, Giorgio Santoni, Massimo Nabissi
Published 2020-07-01

The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies

by Oliviero Marinelli, Oliviero Marinelli, Daniela Annibali, Cristina Aguzzi, Sandra Tuyaerts, Frédéric Amant, Frédéric Amant, Maria Beatrice Morelli, Maria Beatrice Morelli, Giorgio Santoni, Consuelo Amantini, Federica Maggi, Massimo Nabissi
Published 2019-10-01

Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer

by Oliviero Marinelli, Oliviero Marinelli, Daniela Annibali, Maria Beatrice Morelli, Laura Zeppa, Sandra Tuyaerts, Cristina Aguzzi, Consuelo Amantini, Federica Maggi, Benedetta Ferretti, Giorgio Santoni, Frédéric Amant, Frédéric Amant, Massimo Nabissi, Massimo Nabissi
Published 2020-10-01

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

by Sandra Tuyaerts, An M. T. Van Nuffel, Eline Naert, Peter A. Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys
Published 2019-05-01